SUMMARY. We have studied the effect of early exclusion of myocardial infarction using rapid biochemical diagnosis on the management of patients admitted to the coronary care unit of a district general hospital. Diagnosis was based on the rate of creatine kinase increase in serial samples obtained over the 8 h following admission. For an initial 3-month familiarization period serial creatinine kinase results were made available at the end of working day to supplement clinical management, supported by our traditional protocol of admission and daily enzyme determinations. Subsequently, for a 4-month period, the admission to 8 h serial values were provided by 1100 h each day and usually within 24 h of admission. There was a net reduction in length of stay on the coronary care unit to a median 2 days (n = 66) compared with 3 days (n = 41) for patients without further cardiac symptoms or electrocardiographic changes suggestive of ischaemia or infarction. This change was significant, P = O·007, Mann-Whitney U test. Reversion to the original protocol of daily enzyme estimations resulted in an increase in the length of stay on the coronary care unit back to a median of 3 days for this patient group. Rapid diagnostic protocols, applied within routine clinical practice, have the potential for real reduction in coronary care unit stay.
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Acute myocardial infarction (AMI) represents only 23-47% of admissions to the coronary care unit with chest pain.!:" Prompt exclusion of infarction, combined with relevant clinical criteria, would allow appropriate use of scarce (and expensive) coronary care unit beds. Various strategies have been advocated to improve diagnostic accuracy" or patient triage" with this objective.
Electrocardiography (ECG) is the first line investigation in patients with chest pain," more by reason of accessibility rather than accuracy.s-' and diagnosis by biochemical testing may still be required. Patients are often retained on the CCU, and in hospital 'waiting for enzymes'. The usual strategy of measurement of 'cardiac enzymes', Correspondence: Dr P 0 Collinson, Department of Chemical Pathology, Mayday University Hospital, Thornton Heath, Surrey CR7 7YE, UK. on consecutive days will delay final diagnosis and subsequent management, either investigation or transfer for specialist treatment.
We have previously shown that an accurate diagnosis may be achieved 8 to 12 h from admission/-? by serial measurement of CK and calculation of rate of increase (CK slope). We have studied the effect of provision of a rapid diagnosis based on this technique on patient management in a District General Hospital.
METHODS

Patient selection and investigation
All admissions to the coronary care unit were included in a sequential three phase study. Patients were assessed by daily clinical examination, daily electrocardiography and measurement of aspartate transaminase (AST) ? Thrombolytic therapy Retain in CCU and hydroxybutyrate dehydrogenase (HBD) for three consecutive days after admission. During the first and second phases of the study, blood samples were obtained on admission and 2,4 and 8 h later from all patients admitted for confirmation or exclusion of AMI. Samples were separated on the CCU and stored at 4°C. These complete sample series were sent to the laboratory and analysed for CK activity.
All patients in whom myocardial infarction was excluded (for criteria see below) were further investigated to confirm or exclude a diagnosis of ischaemic heart disease and provide a definitive final diagnosis within the period of hospital admission. Stress electrocardiography or thallium scintigraphy, as appropriate, was performed on all patients except those where follow up would occur at other hospitals or when coronary angiography was not considered useful for further Ann Clin Biochem 1993; 30 management. Coronary angiography was performed on patients with positive stress electrocardiograms or thallium scans, or when equivocal investigations were accompanied by a strong clinical suspicion of ischaemic heart disease. When ischaemic heart disease was excluded an alternative diagnosis was sought. Investigations in such patients included radiographic imaging, oesophago-gastroduodenoscopy and isotope ventilation perfusion scintigraphy where indicated. Date of admission, transfer from CCU and hospital discharge were recorded for all cases.
Infarction was judged to have occurred in patients with a history of chest pain accompanied by the development of Q waves, or ischaemic ECG changes and sudden death within 72 h of admission. S-T and T wave changes were taken to indicate infarction when daily AST and HBD values exceeded the upper reference limit or there was evidence from cardiac imaging in patients without previous myocardial infarction (occluded vessels on subsequent angiography, an akinetic or hypo kinetic segment on echocardiography or angiography or a persistent filling defect on thallium scintigraphy).
A diagnosis of angina was made in patients with clinical features suggestive of ischaemic heart disease prior to admission, no further symptoms following admission, no changes in daily AST and HBD values and either transient S-T changes or a positive stress ECG.
Unstable angina was diagnosed in patients with chest pain lasting for 30 min or more when one (or more) of the following occurred after admission: 1 Persistent S-T segment shift or T wave changes without changes in daily AST or HBD values. 2 Further cardiac symptoms with development of S-T segment shift or T wave changes. 3 An initially normal ECG with daily AST and HBD below the upper reference limit during the first 48 h following admission but persistent chest pain and development of either ECG changes typical of myocardial infarction or daily AST and HBD values exceeding the upper reference limit or both 48 h after admission. Non-ischaemic chest pain (NICP) was diagnosed when angina could be excluded by a definitive alternative source of the chest pain or an atypical history with a negative stress ECG.
Laboratory methodology AST and HBD were measured at 37°C by optimized methods on a PERSPECTIVE analyser (American Monitor, West Sussex, UK) by the manufacturer's recommended methods. The manufacturer's reagents were used for AST and commercially supplied reagents used for HBD (Merckotest HBDH, BDH Diagnostics, Dorset, UK). Total CK was measured at 30°C by an optimized method on an RA 1000 (Bayer Diagnostics, Hampshire, UK) using commercially supplied reagents (CK NAC opt, BCL, Sussex, UK).
Diagnostic protocol
The diagnostic protocol used during this period was based on our original studies.t-? modified following studies by other groups,lO,ll and simplified for routine use. It is summarized in Fig.  1 . In patients presenting with acute cardiac symptoms (less than 12 h duration), failure of CK to increase by more than 35010 from the admission value after 8 h hospital stay, [ [(CK at 8 h-CK on admission)/(CK on admission) 1x 100 equal to or less than 35010] was used to exclude acute myocardial infarction. In patients presenting with symptoms of greater than 12 h, or when timing was uncertain, the underlying CK values were examined. Recent myocardial infarction was excluded if all samples remained within the reference range for the laboratory and CK failed to change by more than 35010 over 8 h.
The first phase of the study was to familiarize the clinicians with the protocol. For 3 months serial CK results were provided, together with the usual cardiac enzyme results of admission and daily enzyme determinations, at the end of the working day to supplement clinical management. During the second 4 month phase of the study, the admission to 8 h serial values were provided by 1100 h each day and always within 24 h of admission. The use of serial sampling was then discontinued and for the final 4 month phase the original protocol of admission and daily sampling only was used for biochemical diagnosis. Throughout the study, daily AST and HBD values were provided by 1200 h on the same working day.
During the entire study period, the decision to discharge or transfer the patient was based on the clinical progress of the patient and serial ECG results together with the results of biochemical diagnosis. Patients with unstable angina or arrythmia were retained on the CCU for monitoring.
Length of CCU and hospital stay was examined in all patients in whom acute myocardial infarction had been excluded where monitoring for unstable angina or arrythmia was not clinically indicated. Length of hospital stay was calculated from date of admission, transfer and discharge as whole days (000 to 2400 h). Hence, an admission at 1700 h discharged from hospital at 1100 h the following day will count as 2 days. It was considered that more detailed calculation based on length of stay in hours would not be a realistic assessment of current clinical practice. Median length of stay was determined and the study groups compared by the Mann-Whitney U test.
RESULTS
During the period of study, total workload of the coronary care unit remained stable. Serial sampling was performed on 113 (70'6010) in phase 1 and 152 (73' 8010) in phase 2. Detailed analysis of the Length of stay fell from a median of 3 to 2 days on introduction of the rapid diagnostic service, returning to 3 days when the service was withdrawn ( Table 2 ). Comparison of length of CCU stay for the three successive phases showed the decrease was significant (phase 1 versus phase 2, P = O' 007) with a significant increase following withdrawal (phase 2 versus phase 3, P=0·017). Comparison of phase 1 and phase 3 showed no significant difference in length of CCU stay.
Hospital stay fell from a median of 7 to 5 days but did not increase when the service was withdrawn. Analysis by Mann-Whitney U test showed that only the initial fall was statistically significant (P=O·OO9).
None of the patients transferred from the CCU where acute infarction was excluded by rapid biochemical testing was subsequently found to have had an acute myocardial infarction, or died during this period of hospital stay.
DISCUSSION
Studies on the optimization of coronary care bed utilization have concentrated on the use of clinical and electrocardiography data to assign patients into high and low risk categories of AMI with the objective of reducing false negative admissions to the coronary care unit;' or early transfer to low dependency care." The comment has been made Ann Clin Biochem 1993; 30 that these studies have not changed patient management." We have adopted a different strategy, providing the clinician with a tool for rapidly ruling out acute myocardial infarction, supplementary to clinical findings and the electrocardiogram. These patients could then be transferred for stress electrocardiography or other investigations, as appropriate. This led to a real reduction in CCU stay. Studies that have identified low risk patients who may be appropriate for transfer from the coronary care unit after 24 h have similarly shown significant reduction in length of CCU stay. 13, 14 The use of a 12 h rather than a 24 h protocol has been advocated to prevent the problems of patients presenting in the afternoon or evening and remaining in the CCU for two nights." The use of the 8 h CK sampling protocol, even with determinations performed the following morning, means that the maximum delay will be 24 h, seen only with admissions at 0100 h, with facilities available for morning rounds. This means that the provision of an emergency analytical service is confined to weekends and holiday periods only, and is further reduced by running a batch of samples. Diagnosis by 9 h from admission by provision of an on demand out of hours service is possible. The additional advantage of this strategy remains to be proven.
No effect was seen on the length of hospital stay. Patients on the CCU were managed by the cardiology registrar in accordance with the policy of the CCU director. Once discharged, the patient management passed back to the admitting physician, only one-fifth being subsequently managed by the cardiology consultant. There was a tendency by the other physicians to 'await enzymes' before stress electrocardiography or other testing. The numbers in the subgroups are insufficient to permit sensible comparison of the cardiological and non-cardiological managed groups.
Biochemical diagnosis has been criticized for its lack of contribution to patient management on the coronary care unit. While this may be so as a guide to thrombolysis (although this statement can be questioned"); we have shown that it can be used to rapidly rule out AMI.
A strategy of multiple sequential sampling such as we have used may not be considered acceptable.
In our previous studiesi-? we have defined the maximum percentage increase in CK for samples taken 8-12 h apart in patients presenting within 12h from onset of chest pain. A simpler strategy is therefore possible. To exclude AMI, sampling could be reduced to an admission sample and a second sample taken 8-12 h later. Demonstration of failure of CK to increase by more than 350/0 over this time period when both values remain below the upper reference limit excludes AMI in the patient where the ECG does not change or there are no further symptoms. This will allow early categorization for further management. The use of sequential sampling at more frequent intervals has the potential to identify candidates for thrombolysis" and those where unstable angina is associated with a high risk of progression to infarction;" This study could not be performed as a double blind controlled trial so was potentially subject to a number or errors. The objective was to determine if provision of a rapid 'rule-out' biochemical diagnosis based on a practical and validated method would alter management. It is the timeliness of the diagnosis provided which is under examination, rather than the actual method used. This was achieved by increasing the timeliness of diagnostic information in a stepwise manner.
Potential confounding variables which would alter length of stay must be rigorously controlled. CCU workload throughout the period of study remained constant, hence pressure to admit remained constant. The reduction in length of stay was accompanied by an increase in bed availability on CCU but not accompanied by a rise in CCU admissions, or a decrease in discharges.
The Hawthorne effect cannot be excluded. The possibility was reduced as serial CK results were available during the first phase of the study and monitoring of CCU performance during the entire period of the study was by two observers. Neither observer participated in the clinical decision making process, further reducing the possibility of bias.
The use of whole days rather than hours on CCU might have distorted the figures. Discharges were decided on the basis of the morning review round, hence would occur during the same working day. Patients were not usually transferred or discharged at night. The assumption made is that admissions are randomly distributed, hence any inequalities introduced would be randomly distributed. The possibility that this was not the case has not been categorically excluded. On a pragmatic level hospitals, like hotels, calculate costs in whole days.
In conclusion, we have shown that provision of a rapid biochemical diagnosis, in the context of routine clinical management can produce a real reduction of CCU bed occupancy. Further studies will show if this could be used to produce a reduction in inpatient stay by clinician education and appropriate use of facilities for subsequent patient investigation.
